Drug Shortage Report for TARO-TOFACITINIB

Last updated on 2025-05-12 History
Report ID 250059
Drug Identification Number 02511304
Brand name TARO-TOFACITINIB
Common or Proper name Tofacitinib
Company Name TARO PHARMACEUTICALS INC
Market Status MARKETED
Active Ingredient(s) TOFACITINIB
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 180
ATC code L04AF
ATC description
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2025-01-01
Estimated end date 2025-05-16
Actual end date
Shortage status Actual shortage
Updated date 2025-05-12
Company comments Inventory is available with June 2025 dating
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2025-05-12 French Compare
v7 2025-05-12 English Compare
v6 2025-04-24 French Compare
v5 2025-04-24 English Compare
v4 2025-04-04 French Compare
v3 2025-04-04 English Compare
v2 2025-02-10 French Compare
v1 2025-02-10 English Compare

Showing 1 to 8 of 8